研究業績RESEARCH ACHIEVEMENT
柄山先生、中安先生の論文が海外journalに掲載されました。
呼吸器内科
2024.12.19
柄山先生
Karayama M, Suda T, Yoh K, Usui K, Hosomi Y, Kishi K, Naka G, Watanabe K, Tamano S, Uemura K, Kunitoh H. Difference in efficacy of osimertinib between patients with EGFR-positive NSCLC with postoperative recurrence and those with de novo unresectable disease: A prospective, observational study. Lung Cancer. 2024 Dec;198:108037. doi: 10.1016/j.lungcan.2024.108037. Epub 2024 Nov 26. PMID: 39602849.
中安先生
Nakayasu H, Karayama M, Enomoto N, Inoue Y, Yasui H, Suzuki Y, Hozumi H, Furuhashi K, Kono M, Toyoshima M, Imokawa S, Fujii M, Akamatsu T, Koshimizu N, Yokomura K, Matsuda H, Kaida Y, Nakamura Y, Shirai M, Masuda M, Fujisawa T, Inui N, Sugiura H, Sumikawa H, Kitani M, Tabata K, Ogawa N, Suda T. Association between the HAL score and the development of progressive pulmonary fibrosis in idiopathic interstitial pneumonia: A prospective observational study. Respir Investig. 2024 Dec 17;63(1):138-145. doi: 10.1016/j.resinv.2024.12.011. Epub ahead of print. PMID: 39693847.
Karayama M, Suda T, Yoh K, Usui K, Hosomi Y, Kishi K, Naka G, Watanabe K, Tamano S, Uemura K, Kunitoh H. Difference in efficacy of osimertinib between patients with EGFR-positive NSCLC with postoperative recurrence and those with de novo unresectable disease: A prospective, observational study. Lung Cancer. 2024 Dec;198:108037. doi: 10.1016/j.lungcan.2024.108037. Epub 2024 Nov 26. PMID: 39602849.
中安先生
Nakayasu H, Karayama M, Enomoto N, Inoue Y, Yasui H, Suzuki Y, Hozumi H, Furuhashi K, Kono M, Toyoshima M, Imokawa S, Fujii M, Akamatsu T, Koshimizu N, Yokomura K, Matsuda H, Kaida Y, Nakamura Y, Shirai M, Masuda M, Fujisawa T, Inui N, Sugiura H, Sumikawa H, Kitani M, Tabata K, Ogawa N, Suda T. Association between the HAL score and the development of progressive pulmonary fibrosis in idiopathic interstitial pneumonia: A prospective observational study. Respir Investig. 2024 Dec 17;63(1):138-145. doi: 10.1016/j.resinv.2024.12.011. Epub ahead of print. PMID: 39693847.